EDGAR Filing Documents for 0000909661-03-000039

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

SEC Accession No. 0000909661-03-000039

Filing Date

2003-07-02

Accepted

2003-07-02 17:28:22

Documents

Group Members

CHUN R. DINGDAVID I. COHENDEREK C. SCHRIERFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL PARTNERS, L.P.FARALLON PARTNERS, L.L.C.JOSEPH F. DOWNE

Document Format Files

Seq	Description	Document	Type	Size
1	SALIX 13D/A #1 FILED 7/2/03	salix13da_july2-2003.txt	SC 13D/A	102638
	Complete submission text file	0000909661-03-000039.txt		105469

Mailing Address ONE MARITIME PLAZA SAN FRANCISCO CA 94111

Business Address ONE MARITIME PLAZA STE 11325 SAN FRANCISCO CA 94111 4154212132

FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279

Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615

Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000

SALIX PHARMACEUTICALS LTD (Subject) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-53269 | Film No.: 03773047
SIC: 2834 Pharmaceutical Preparations